TipRanks
Voyageur Pharmaceuticals (TSE:VM)
:VM
Canadian Market
VM
Voyageur Pharmaceuticals
RESEARCH TOOLSreports
Want to see TSE:VM full AI Analyst Report?

Voyageur Pharmaceuticals (VM) Ratios

20 Followers

Voyageur Pharmaceuticals Ratios

TSE:VM's free cash flow for Q2 2026 was C$-50.70. For the 2026 fiscal year, TSE:VM's free cash flow was decreased by C$ and operating cash flow was C$-61.24. See a summary of the company’s cash flow.
Ratios
TTM
Feb 26Feb 25Feb 24Feb 23
Liquidity Ratios
Current Ratio
 0.23 0.33 0.17 0.13 0.27
Quick Ratio
 0.19 0.30 0.14 0.12 0.25
Cash Ratio
 0.16 0.15 0.08 <0.01 0.05
Solvency Ratio
 -1.35 -1.91 -0.79 -1.92 -2.78
Operating Cash Flow Ratio
 -0.36 -1.60 -0.14 -1.47 -2.91
Short-Term Operating Cash Flow Coverage
 -25.33 0.00 0.00 0.00 0.00
Net Current Asset Value
C$ -2.17MC$ -1.26MC$ -1.79MC$ -639.25KC$ -473.65K
Leverage Ratios
Debt-to-Assets Ratio
 0.01 0.01 0.02 0.02 0.01
Debt-to-Equity Ratio
 0.10 0.03 0.09 0.03 0.02
Debt-to-Capital Ratio
 0.09 0.03 0.08 0.03 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.03 0.08 0.03 0.02
Financial Leverage Ratio
 7.88 2.48 5.77 1.51 1.43
Debt Service Coverage Ratio
 -94.91 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 0.11 0.06 0.07 -0.03 <0.01
Profitability Margins
Gross Profit Margin
-4603.48%-10466.55%0.00%0.00%0.00%
EBIT Margin
-8038.56%-30231.56%0.00%0.00%0.00%
EBITDA Margin
-8036.16%-30221.87%0.00%0.00%0.00%
Operating Profit Margin
-8038.56%-30231.56%0.00%0.00%0.00%
Pretax Profit Margin
-8033.93%-30231.56%0.00%0.00%0.00%
Net Profit Margin
-8033.93%-30231.56%0.00%0.00%0.00%
Continuous Operations Profit Margin
-8033.93%-30231.56%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
99.94%100.00%100.47%114.62%100.23%
Return on Assets (ROA)
-117.95%-113.77%-65.70%-64.68%-83.70%
Return on Equity (ROE)
-403.29%-282.05%-379.42%-97.47%-119.75%
Return on Capital Employed (ROCE)
-930.25%-273.32%-337.19%-81.95%-116.35%
Return on Invested Capital (ROIC)
-847.23%-273.32%-337.19%-81.95%-116.35%
Return on Tangible Assets
-117.95%-113.77%-65.70%-64.68%-83.70%
Earnings Yield
-12.47%-12.92%-19.08%-26.81%-23.24%
Efficiency Ratios
Receivables Turnover
 0.94 0.09 0.00 0.00 0.00
Payables Turnover
 1.64 0.85 <0.01 0.01 <0.01
Inventory Turnover
 18.34 25.11 0.02 0.21 0.28
Fixed Asset Turnover
 18.47 3.74 0.00 0.00 0.00
Asset Turnover
 0.01 <0.01 0.00 0.00 0.00
Working Capital Turnover Ratio
 -0.02 >-0.01 0.00 0.00 0.00
Cash Conversion Cycle
 185.21 3.77K -195.79K -34.69K -72.92K
Days of Sales Outstanding
 387.96 4.19K 0.00 0.00 0.00
Days of Inventory Outstanding
 19.90 14.54 15.54K 1.72K 1.30K
Days of Payables Outstanding
 222.65 430.08 211.33K 36.42K 74.22K
Operating Cycle
 407.86 4.20K 15.54K 1.72K 1.30K
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 -0.02 >-0.01 >-0.01 -0.02
Free Cash Flow Per Share
 >-0.01 -0.02 >-0.01 >-0.01 -0.02
CapEx Per Share
 <0.01 <0.01 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.16
Dividend Paid and CapEx Coverage Ratio
 -337.72K -578.56K 0.00 -5.67K -6.08
Capital Expenditure Coverage Ratio
 -337.72K -578.56K 0.00 -5.67K -6.08
Operating Cash Flow Coverage Ratio
 -25.33 -72.32 -7.56 -24.78 -67.35
Operating Cash Flow to Sales Ratio
 -21.45 -247.56 0.00 0.00 0.00
Free Cash Flow Yield
-3.32%-10.58%-3.38%-18.99%-26.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -7.83 -7.75 -5.24 -3.73 -4.30
Price-to-Sales (P/S) Ratio
 645.88 2.34K 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 74.55 21.82 19.88 3.64 5.15
Price-to-Free Cash Flow (P/FCF) Ratio
 -30.11 -9.45 -29.59 -5.27 -3.77
Price-to-Operating Cash Flow Ratio
 -30.04 -9.45 -29.59 -5.27 -4.39
Price-to-Earnings Growth (PEG) Ratio
 0.18 -0.11 -0.33 0.11 0.17
Price-to-Fair Value
 74.55 21.82 19.88 3.64 5.15
Enterprise Value Multiple
 -7.93 -7.68 -5.17 -4.31 -4.31
Enterprise Value
 30.11M 27.11M 8.82M 5.26M 7.54M
EV to EBITDA
 -7.93 -7.68 -5.17 -4.31 -4.31
EV to Sales
 637.38 2.32K 0.00 0.00 0.00
EV to Free Cash Flow
 -29.72 -9.37 -29.18 -5.30 -3.77
EV to Operating Cash Flow
 -29.72 -9.37 -29.18 -5.30 -4.39
Tangible Book Value Per Share
 <0.01 <0.01 <0.01 0.01 0.01
Shareholders’ Equity Per Share
 <0.01 <0.01 <0.01 0.01 0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 >-0.01
Revenue Per Share
 <0.01 <0.01 0.00 0.00 0.00
Net Income Per Share
 -0.02 -0.02 -0.01 -0.01 -0.02
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.00 1.00 1.00 1.14 1.00
Research & Development to Revenue
 24.29 77.68 0.00 0.00 0.00
SG&A to Revenue
 28.22 119.97 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.27 0.82 0.18 0.71 0.98
Currency in CAD